1H-PYRAZOLO[4,3-C]PYRIDINE-6-CARBOXYLIC ACID, 95%, 1g

2-Hydroxyisophthalaldehyde, 95.0%, 1g

N-Methyl-1-(3,4,5-trifluorophenyl)methanamine, 500mg

Transition piece, 29/32, 19/26, 1 Piece

(S)-3-(hydroxymethyl)-N-((S)-1-(naphthalen-1-yl)ethyl)pent-4-enamide, 97%, 500mg

Quinazolin-7-ylboronic acid, 95.0%, 5g

5,7-Difluoro-3-methyl-1-benzofuran-2-carboxylic acid, 95.0%, 10g

{[5-(4-Fluorophenyl)isoxazol-3-yl]methyl}amine hydrochloride, 95.0%, 500mg

4,5-Dichloroquinazoline, 95.0%, 1g

4-(Methoxycarbonyl)benzoic acid, 97.0%, 5g

2-Phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine hydrochloride, 98%, 100mg

tri-lithium citrate tetrahydrate, min. 98%, Ph.Eur., 500 g, plastic packaging.

4-Benzyloxyphenylacetic acid methyl ester, 95.0%, 10g